Actualités CorMedix Inc - CRMD | Actions NASDAQ | ADVFN

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

CorMedix Inc (CRMD)

8,21

-0,29

(-3,41%)

Fermé 28 Décembre 10:00PM

Retardé de 15 minutes

8,21

0,005

(0,06%)

Après les heures de négociation: 1:54AM

Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form DEF 14A - Other definitive proxy statements

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

CorMedix Inc. Receives FDA Feedback on Potential Label Expansion

BERKELEY HEIGHTS, N.J., June 18, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical...

CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath

BERKELEY HEIGHTS, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical...

Form EFFECT - Notice of Effectiveness

Form 4 - Statement of changes in beneficial ownership of securities

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Societe Generale Effekten

Exchange Traded

Societe Generale Effekten

Ssga Spdr Barclays 10 Ye...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales